Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Naoki Iwamoto

Showing results (31-40 of 217) with videos related to

Pageof 22
Sort By:
BMC Immunology|February 5, 2017
Tumor necrosis factor alpha inhibitors have no effect on a human T-lymphotropic virus type-I (HTLV-I)-infected cell line from patients with HTLV-I-associated myelopathyShoichi Fukui, Hideki Nakamura, Yoshiko Takahashi, et al.
BMC Musculoskeletal Disorders|July 2, 2010
Anti-centromere antibody-seropositive Sjögren's syndrome differs from conventional subgroup in clinical and pathological studyHideki Nakamura, Atsushi Kawakami, Tomayoshi Hayashi, et al.
Frontiers in Immunology|March 17, 2023
Evaluation of a renal risk score for Japanese patients with ANCA-associated glomerulonephritis in a multi-center cohort studyTomohisa Uchida, Kunihiro Ichinose, Ayuko Yamashita, et al.
Atherosclerosis|April 13, 2005
Disruption of tumor necrosis factor-alpha gene diminishes the development of atherosclerosis in ApoE-deficient miceHirotoshi Ohta, Hisayasu Wada, Tamikazu Niwa, et al.
Modern Rheumatology|January 16, 2024
Association of denosumab with serum cytokines, chemokines, and bone-related factors in patients with rheumatoid arthritis: A post hoc analysis of a multicentre, open-label, randomised, parallel-group studyNaoki Iwamoto, Shuntaro Sato, Kaori Furukawa, et al.
Journal of Atherosclerosis and Thrombosis|May 22, 2004
Interferon-gamma produced by bone marrow-derived cells attenuates atherosclerotic lesion formation in LDLR-deficient miceTamikazu Niwa, Hisayasu Wada, Hazuki Ohashi, et al.
Internal Medicine (Tokyo, Japan)|December 24, 2025
Improvement of Lymphedema in IgG4-Related Disease with Oral Glucocorticoid TherapyYuta Matsushita, Masataka Umeda, Hirokazu Kurohama, et al.
Biological & Pharmaceutical Bulletin|September 17, 2002
Antidiabetic activity of Lyophyllum decastes in genetically type 2 diabetic miceToshihiro Miura, Mizue Kubo, Yasushi Itoh, et al.
Rheumatology (Oxford, England)|February 16, 2023
Comparison of risks of cancer, infection, and MACEs associated with JAK inhibitor and TNF inhibitor treatment: a multicentre cohort studyTomohisa Uchida, Naoki Iwamoto, Shoichi Fukui, et al.
Trials|August 15, 2019
Comparative study of the inhibitory effect on bone erosion progression with denosumab treatment and conventional treatment in rheumatoid arthritis patients: study protocol for an open-label randomized controlled trial by HR-pQCTNaoki Iwamoto, Shuntaro Sato, Remi Sumiyoshi, et al.
Pageof 22

Showing results (31-40 of 217) with videos related to

Sort By:
Pageof 22
BMC Immunology|February 5, 2017
Tumor necrosis factor alpha inhibitors have no effect on a human T-lymphotropic virus type-I (HTLV-I)-infected cell line from patients with HTLV-I-associated myelopathyShoichi Fukui, Hideki Nakamura, Yoshiko Takahashi, et al.
BMC Musculoskeletal Disorders|July 2, 2010
Anti-centromere antibody-seropositive Sjögren's syndrome differs from conventional subgroup in clinical and pathological studyHideki Nakamura, Atsushi Kawakami, Tomayoshi Hayashi, et al.
Frontiers in Immunology|March 17, 2023
Evaluation of a renal risk score for Japanese patients with ANCA-associated glomerulonephritis in a multi-center cohort studyTomohisa Uchida, Kunihiro Ichinose, Ayuko Yamashita, et al.
Atherosclerosis|April 13, 2005
Disruption of tumor necrosis factor-alpha gene diminishes the development of atherosclerosis in ApoE-deficient miceHirotoshi Ohta, Hisayasu Wada, Tamikazu Niwa, et al.
Modern Rheumatology|January 16, 2024
Association of denosumab with serum cytokines, chemokines, and bone-related factors in patients with rheumatoid arthritis: A post hoc analysis of a multicentre, open-label, randomised, parallel-group studyNaoki Iwamoto, Shuntaro Sato, Kaori Furukawa, et al.
Journal of Atherosclerosis and Thrombosis|May 22, 2004
Interferon-gamma produced by bone marrow-derived cells attenuates atherosclerotic lesion formation in LDLR-deficient miceTamikazu Niwa, Hisayasu Wada, Hazuki Ohashi, et al.
Internal Medicine (Tokyo, Japan)|December 24, 2025
Improvement of Lymphedema in IgG4-Related Disease with Oral Glucocorticoid TherapyYuta Matsushita, Masataka Umeda, Hirokazu Kurohama, et al.
Biological & Pharmaceutical Bulletin|September 17, 2002
Antidiabetic activity of Lyophyllum decastes in genetically type 2 diabetic miceToshihiro Miura, Mizue Kubo, Yasushi Itoh, et al.
Rheumatology (Oxford, England)|February 16, 2023
Comparison of risks of cancer, infection, and MACEs associated with JAK inhibitor and TNF inhibitor treatment: a multicentre cohort studyTomohisa Uchida, Naoki Iwamoto, Shoichi Fukui, et al.
Trials|August 15, 2019
Comparative study of the inhibitory effect on bone erosion progression with denosumab treatment and conventional treatment in rheumatoid arthritis patients: study protocol for an open-label randomized controlled trial by HR-pQCTNaoki Iwamoto, Shuntaro Sato, Remi Sumiyoshi, et al.
Pageof 22